Cue Biopharma is trading at $31.66 (+13.03%) as part of a broader risk-on rebound in equities and the biotechnology sector.
- The move aligns with a wider market rally led by growth names, with the Nasdaq Composite gaining 2.63% during the session.
- No company-specific announcements or catalysts have been identified, suggesting the price action is driven by macro sentiment.
- Analysts note the stock is rebounding following a prior pullback, consistent with current trends in the biotech space.